Global Growth Hormone Deficiency Treatment Market Research Report 2023

Report ID: 1898310 | Published Date: Jan 2025 | No. of Page: 84 | Base Year: 2024 | Rating: 4.2 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Growth Hormone Deficiency Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Pharmacological Therapy
        1.2.3 Recombinant Human Growth Hormone
        1.2.4 Human Pituitary Gland Extracts
    1.3 Market by Application
        1.3.1 Global Growth Hormone Deficiency Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Home Care Settings
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Growth Hormone Deficiency Treatment Market Perspective (2017-2028)
    2.2 Growth Hormone Deficiency Treatment Growth Trends by Region
        2.2.1 Growth Hormone Deficiency Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Growth Hormone Deficiency Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Growth Hormone Deficiency Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Growth Hormone Deficiency Treatment Market Dynamics
        2.3.1 Growth Hormone Deficiency Treatment Industry Trends
        2.3.2 Growth Hormone Deficiency Treatment Market Drivers
        2.3.3 Growth Hormone Deficiency Treatment Market Challenges
        2.3.4 Growth Hormone Deficiency Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Growth Hormone Deficiency Treatment Players by Revenue
        3.1.1 Global Top Growth Hormone Deficiency Treatment Players by Revenue (2017-2022)
        3.1.2 Global Growth Hormone Deficiency Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Growth Hormone Deficiency Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Growth Hormone Deficiency Treatment Revenue
    3.4 Global Growth Hormone Deficiency Treatment Market Concentration Ratio
        3.4.1 Global Growth Hormone Deficiency Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Growth Hormone Deficiency Treatment Revenue in 2021
    3.5 Growth Hormone Deficiency Treatment Key Players Head office and Area Served
    3.6 Key Players Growth Hormone Deficiency Treatment Product Solution and Service
    3.7 Date of Enter into Growth Hormone Deficiency Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Growth Hormone Deficiency Treatment Breakdown Data by Type
    4.1 Global Growth Hormone Deficiency Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Growth Hormone Deficiency Treatment Forecasted Market Size by Type (2023-2028)
5 Growth Hormone Deficiency Treatment Breakdown Data by Application
    5.1 Global Growth Hormone Deficiency Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Growth Hormone Deficiency Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Growth Hormone Deficiency Treatment Market Size (2017-2028)
    6.2 North America Growth Hormone Deficiency Treatment Market Size by Country (2017-2022)
    6.3 North America Growth Hormone Deficiency Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Growth Hormone Deficiency Treatment Market Size (2017-2028)
    7.2 Europe Growth Hormone Deficiency Treatment Market Size by Country (2017-2022)
    7.3 Europe Growth Hormone Deficiency Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Growth Hormone Deficiency Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Growth Hormone Deficiency Treatment Market Size (2017-2028)
    9.2 Latin America Growth Hormone Deficiency Treatment Market Size by Country (2017-2022)
    9.3 Latin America Growth Hormone Deficiency Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Growth Hormone Deficiency Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Sandoz International
        11.1.1 Sandoz International Company Detail
        11.1.2 Sandoz International Business Overview
        11.1.3 Sandoz International Growth Hormone Deficiency Treatment Introduction
        11.1.4 Sandoz International Revenue in Growth Hormone Deficiency Treatment Business (2017-2022)
        11.1.5 Sandoz International Recent Development
    11.2 Sanofi Aventis
        11.2.1 Sanofi Aventis Company Detail
        11.2.2 Sanofi Aventis Business Overview
        11.2.3 Sanofi Aventis Growth Hormone Deficiency Treatment Introduction
        11.2.4 Sanofi Aventis Revenue in Growth Hormone Deficiency Treatment Business (2017-2022)
        11.2.5 Sanofi Aventis Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Detail
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Growth Hormone Deficiency Treatment Introduction
        11.3.4 Pfizer Revenue in Growth Hormone Deficiency Treatment Business (2017-2022)
        11.3.5 Pfizer Recent Development
    11.4 Novo Nordisk
        11.4.1 Novo Nordisk Company Detail
        11.4.2 Novo Nordisk Business Overview
        11.4.3 Novo Nordisk Growth Hormone Deficiency Treatment Introduction
        11.4.4 Novo Nordisk Revenue in Growth Hormone Deficiency Treatment Business (2017-2022)
        11.4.5 Novo Nordisk Recent Development
    11.5 Teva Pharmaceutical
        11.5.1 Teva Pharmaceutical Company Detail
        11.5.2 Teva Pharmaceutical Business Overview
        11.5.3 Teva Pharmaceutical Growth Hormone Deficiency Treatment Introduction
        11.5.4 Teva Pharmaceutical Revenue in Growth Hormone Deficiency Treatment Business (2017-2022)
        11.5.5 Teva Pharmaceutical Recent Development
    11.6 Ranbaxy
        11.6.1 Ranbaxy Company Detail
        11.6.2 Ranbaxy Business Overview
        11.6.3 Ranbaxy Growth Hormone Deficiency Treatment Introduction
        11.6.4 Ranbaxy Revenue in Growth Hormone Deficiency Treatment Business (2017-2022)
        11.6.5 Ranbaxy Recent Development
    11.7 EMD Serono
        11.7.1 EMD Serono Company Detail
        11.7.2 EMD Serono Business Overview
        11.7.3 EMD Serono Growth Hormone Deficiency Treatment Introduction
        11.7.4 EMD Serono Revenue in Growth Hormone Deficiency Treatment Business (2017-2022)
        11.7.5 EMD Serono Recent Development
    11.8 Sun Pharmaceutical
        11.8.1 Sun Pharmaceutical Company Detail
        11.8.2 Sun Pharmaceutical Business Overview
        11.8.3 Sun Pharmaceutical Growth Hormone Deficiency Treatment Introduction
        11.8.4 Sun Pharmaceutical Revenue in Growth Hormone Deficiency Treatment Business (2017-2022)
        11.8.5 Sun Pharmaceutical Recent Development
    11.9 Eli Lilly
        11.9.1 Eli Lilly Company Detail
        11.9.2 Eli Lilly Business Overview
        11.9.3 Eli Lilly Growth Hormone Deficiency Treatment Introduction
        11.9.4 Eli Lilly Revenue in Growth Hormone Deficiency Treatment Business (2017-2022)
        11.9.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Growth Hormone Deficiency Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Pharmacological Therapy
    Table 3. Key Players of Recombinant Human Growth Hormone
    Table 4. Key Players of Human Pituitary Gland Extracts
    Table 5. Global Growth Hormone Deficiency Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Growth Hormone Deficiency Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Growth Hormone Deficiency Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Growth Hormone Deficiency Treatment Market Share by Region (2017-2022)
    Table 9. Global Growth Hormone Deficiency Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Growth Hormone Deficiency Treatment Market Share by Region (2023-2028)
    Table 11. Growth Hormone Deficiency Treatment Market Trends
    Table 12. Growth Hormone Deficiency Treatment Market Drivers
    Table 13. Growth Hormone Deficiency Treatment Market Challenges
    Table 14. Growth Hormone Deficiency Treatment Market Restraints
    Table 15. Global Growth Hormone Deficiency Treatment Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Growth Hormone Deficiency Treatment Market Share by Players (2017-2022)
    Table 17. Global Top Growth Hormone Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Growth Hormone Deficiency Treatment as of 2021)
    Table 18. Ranking of Global Top Growth Hormone Deficiency Treatment Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Growth Hormone Deficiency Treatment Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Growth Hormone Deficiency Treatment Product Solution and Service
    Table 22. Date of Enter into Growth Hormone Deficiency Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Growth Hormone Deficiency Treatment Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Growth Hormone Deficiency Treatment Revenue Market Share by Type (2017-2022)
    Table 26. Global Growth Hormone Deficiency Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Growth Hormone Deficiency Treatment Revenue Market Share by Type (2023-2028)
    Table 28. Global Growth Hormone Deficiency Treatment Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Growth Hormone Deficiency Treatment Revenue Market Share by Application (2017-2022)
    Table 30. Global Growth Hormone Deficiency Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Growth Hormone Deficiency Treatment Revenue Market Share by Application (2023-2028)
    Table 32. North America Growth Hormone Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Growth Hormone Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Growth Hormone Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Growth Hormone Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Growth Hormone Deficiency Treatment Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Growth Hormone Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Growth Hormone Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Growth Hormone Deficiency Treatment Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Sandoz International Company Detail
    Table 43. Sandoz International Business Overview
    Table 44. Sandoz International Growth Hormone Deficiency Treatment Product
    Table 45. Sandoz International Revenue in Growth Hormone Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 46. Sandoz International Recent Development
    Table 47. Sanofi Aventis Company Detail
    Table 48. Sanofi Aventis Business Overview
    Table 49. Sanofi Aventis Growth Hormone Deficiency Treatment Product
    Table 50. Sanofi Aventis Revenue in Growth Hormone Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 51. Sanofi Aventis Recent Development
    Table 52. Pfizer Company Detail
    Table 53. Pfizer Business Overview
    Table 54. Pfizer Growth Hormone Deficiency Treatment Product
    Table 55. Pfizer Revenue in Growth Hormone Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 56. Pfizer Recent Development
    Table 57. Novo Nordisk Company Detail
    Table 58. Novo Nordisk Business Overview
    Table 59. Novo Nordisk Growth Hormone Deficiency Treatment Product
    Table 60. Novo Nordisk Revenue in Growth Hormone Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 61. Novo Nordisk Recent Development
    Table 62. Teva Pharmaceutical Company Detail
    Table 63. Teva Pharmaceutical Business Overview
    Table 64. Teva Pharmaceutical Growth Hormone Deficiency Treatment Product
    Table 65. Teva Pharmaceutical Revenue in Growth Hormone Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 66. Teva Pharmaceutical Recent Development
    Table 67. Ranbaxy Company Detail
    Table 68. Ranbaxy Business Overview
    Table 69. Ranbaxy Growth Hormone Deficiency Treatment Product
    Table 70. Ranbaxy Revenue in Growth Hormone Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 71. Ranbaxy Recent Development
    Table 72. EMD Serono Company Detail
    Table 73. EMD Serono Business Overview
    Table 74. EMD Serono Growth Hormone Deficiency Treatment Product
    Table 75. EMD Serono Revenue in Growth Hormone Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 76. EMD Serono Recent Development
    Table 77. Sun Pharmaceutical Company Detail
    Table 78. Sun Pharmaceutical Business Overview
    Table 79. Sun Pharmaceutical Growth Hormone Deficiency Treatment Product
    Table 80. Sun Pharmaceutical Revenue in Growth Hormone Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 81. Sun Pharmaceutical Recent Development
    Table 82. Eli Lilly Company Detail
    Table 83. Eli Lilly Business Overview
    Table 84. Eli Lilly Growth Hormone Deficiency Treatment Product
    Table 85. Eli Lilly Revenue in Growth Hormone Deficiency Treatment Business (2017-2022) & (US$ Million)
    Table 86. Eli Lilly Recent Development
    Table 87. Research Programs/Design for This Report
    Table 88. Key Data Information from Secondary Sources
    Table 89. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Growth Hormone Deficiency Treatment Market Share by Type: 2021 VS 2028
    Figure 2. Pharmacological Therapy Features
    Figure 3. Recombinant Human Growth Hormone Features
    Figure 4. Human Pituitary Gland Extracts Features
    Figure 5. Global Growth Hormone Deficiency Treatment Market Share by Application in 2021 & 2028
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Home Care Settings Case Studies
    Figure 9. Growth Hormone Deficiency Treatment Report Years Considered
    Figure 10. Global Growth Hormone Deficiency Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Growth Hormone Deficiency Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Growth Hormone Deficiency Treatment Market Share by Region: 2021 VS 2028
    Figure 13. Global Growth Hormone Deficiency Treatment Market Share by Players in 2021
    Figure 14. Global Top Growth Hormone Deficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Growth Hormone Deficiency Treatment as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Growth Hormone Deficiency Treatment Revenue in 2021
    Figure 16. North America Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Growth Hormone Deficiency Treatment Market Share by Country (2017-2028)
    Figure 18. United States Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Growth Hormone Deficiency Treatment Market Share by Country (2017-2028)
    Figure 22. Germany Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Growth Hormone Deficiency Treatment Market Share by Region (2017-2028)
    Figure 30. China Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Growth Hormone Deficiency Treatment Market Share by Country (2017-2028)
    Figure 38. Mexico Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Growth Hormone Deficiency Treatment Market Share by Country (2017-2028)
    Figure 42. Turkey Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Growth Hormone Deficiency Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Sandoz International Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2017-2022)
    Figure 45. Sanofi Aventis Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2017-2022)
    Figure 46. Pfizer Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2017-2022)
    Figure 47. Novo Nordisk Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2017-2022)
    Figure 48. Teva Pharmaceutical Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2017-2022)
    Figure 49. Ranbaxy Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2017-2022)
    Figure 50. EMD Serono Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2017-2022)
    Figure 51. Sun Pharmaceutical Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2017-2022)
    Figure 52. Eli Lilly Revenue Growth Rate in Growth Hormone Deficiency Treatment Business (2017-2022)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sandoz International
Sanofi Aventis
Pfizer
Novo Nordisk
Teva Pharmaceutical
Ranbaxy
EMD Serono
Sun Pharmaceutical
Eli Lilly
Frequently Asked Questions
Growth Hormone Deficiency Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Growth Hormone Deficiency Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Growth Hormone Deficiency Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Guava Puree

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More